| CD4 baseline |
|
1.000784 (1.0007, 1.0008) |
0.000 |
| Gender |
Female |
1 (Ref.) |
|
| Male |
0.79 (0.78, 0.81) |
0.000 |
| Pregnant mothers (n = 12866) |
No |
1 (Ref.) |
|
| Yes |
1.07 (0.97, 1.19) |
0.194 |
| Lactating mothers (n = 12866) |
No |
1 (Ref.) |
|
| Yes |
1.08 (1.01, 1.16) |
0.022 |
| Age category |
15–19 |
1 (Ref.) |
|
| 20–24 |
0.88 (0.82, 0.95) |
0.001 |
| 25–29 |
0.82 (0.77, 0.87) |
0.000 |
| 30–34 |
0.81 (0.77, 0.87) |
0.000 |
| 35–39 |
0.76 (0.72, 0.81) |
0.000 |
| 40–44 |
0.72 (0.68, 0.76) |
0.000 |
| 45–49 |
0.70 (0.66, 0.74) |
0.000 |
| 50+ |
0.69 (0.65, 0.73) |
0.000 |
| Facility ownership |
Government |
1 (Ref.) |
|
| Non-governmental organization |
1.02 (0.98, 1.06) |
0.432 |
| Private |
1.21 (0.94, 1.56) |
0.131 |
| Facility type |
Clinic |
1 (Ref.) |
|
| Health center |
0.82 (0.72, 0.94) |
0.003 |
| Primary hospital |
0.84 (0.73, 0.96) |
0.01 |
| General hospital |
0.91 (0.80, 1.04) |
0.165 |
| Referral Hospital |
0.79 (0.69, 0.91) |
0.001 |
| Other |
1.01 (0.87, 1.17) |
0.881 |
| A service provided at military health care facility |
No |
1 (Ref.) |
|
| Yes |
0.92 (0.88, 0.95) |
0.000 |
| WHO Stage |
I |
1 (Ref.) |
|
| II |
0.86 (0.82, 0.91) |
0.000 |
| III |
0.78 (0.73, 0.83) |
0.000 |
| IV |
0.98 (0.93, 1.03) |
0.423 |
| Adherence |
Poor |
1 (Ref.) |
|
| Fair |
1.07 (0.97, 1.17) |
0.186 |
| Good |
1.32 (1.22, 1.43) |
0.000 |
| Virological test reason |
Routine first VL (6 Months or more on ART) |
1 (Ref.) |
|
| Routine annual VL test |
1.02 (1.001, 1.04) |
0.041 |
| Suspected ART failure clinical |
0.64 (0.51, 0.80) |
0.000 |
| Suspected ART failure immunological |
0.46 (0.37, 0.56) |
0.000 |
| Suspected ART failure initial VL |
0.67 (0.65, 0.70) |
0.000 |
| Not indicated in the form |
0.93 (0.87, 0.998) |
0.042 |
| Regimen |
1c (AZT-3TC-NVP) |
1 (Ref.) |
|
| 1d (AZT-3TC-EFV) |
0.97 (0.94, 0.999) |
0.047 |
| 1e (TDF-3TC-EFV) |
0.97 (0.95, 0.98) |
0.000 |
| 1f (TDF + 3TC+ NVP) |
0.98 (0.96, 1.01) |
0.261 |
| 1g (ABC + 3TC + EFV) |
0.96 (0.70, 1.31) |
0.778 |
| 1h (ABC + 3TC NVP) |
0.69 (0.44, 1.09) |
0.114 |
| 2a (ABC-ddl-LPV/R), 2c (TDF-ddl-LPV/R), 2d(TDF-ddl-NFV)& 2g (TDF-3TC-LPV/r) |
0.68 (0.43, 1.08) |
0.101 |
| 2f (AZT-3TC-ATV/r) |
0.59 (0.50, 0.71) |
0.000 |
| 2h (TDF-3TC-ATV/r) |
0.65 (0.57, 0.74) |
0.000 |
| Treatment line |
First line |
1 (Ref.) |
|
| Second line |
0.65 (0.0.59, 0.72) |
0.000 |
| Viral load suppression |
No |
1 (Ref.) |
|
| Yes |
1.40 (1.36, 1.43) |
0.000 |
